Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group
出版年份 2013 全文链接
标题
Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group
作者
关键词
Stem cell transplantation, Cyclin D1, Cytarabine, Immunochemotherapy, Ki-67, Maintenance therapy, Mantle cell lymphoma, Minimal residual disease, Prognostic factors, Proliferation index, Salvage therapy
出版物
ANNALS OF HEMATOLOGY
Volume 92, Issue 9, Pages 1151-1179
出版商
Springer Nature
发表日期
2013-05-28
DOI
10.1007/s00277-013-1783-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
- (2013) Mathias J Rummel et al. LANCET
- CCND2 rearrangements are the most frequent genetic events in cyclin D1- mantle cell lymphoma
- (2012) I. Salaverria et al. BLOOD
- Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
- (2012) L. Nygren et al. BLOOD
- CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte
- (2012) R. Delarue et al. BLOOD
- Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
- (2012) A. Navarro et al. CANCER RESEARCH
- A highly sensitive and specific qPCR assay for quantification of the biomarkerSOX11in mantle cell lymphoma
- (2012) Kristiane Hornung Hamborg et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease
- (2012) C Royo et al. LEUKEMIA
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- Treatment of Older Patients with Mantle-Cell Lymphoma
- (2012) H.C. Kluin-Nelemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
- (2011) E. Jantunen et al. ANNALS OF ONCOLOGY
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
- (2011) S. L. Ondrejka et al. HAEMATOLOGICA
- Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
- (2011) F. Zaja et al. HAEMATOLOGICA
- Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma
- (2011) W. Lamm et al. HAEMATOLOGICA
- In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
- (2011) A. Carvajal-Cuenca et al. HAEMATOLOGICA
- Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909
- (2011) H. Liu et al. HAEMATOLOGICA
- Indolent Mantle-Cell Lymphoma: Immunoglobulin Variable Region Heavy Chain Sequence Analysis Reveals Evidence of Disease 10 Years Prior to Symptomatic Clinical Presentation
- (2011) Simon A.J. Rule et al. JOURNAL OF CLINICAL ONCOLOGY
- Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation
- (2011) Lihua E. Budde et al. JOURNAL OF CLINICAL ONCOLOGY
- Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
- (2011) Stephen M Ansell et al. LANCET ONCOLOGY
- Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
- (2010) M. Aapro et al. ANNALS OF ONCOLOGY
- Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation
- (2010) Gordon Cook et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma
- (2010) Jorge E. Romaguera et al. BRITISH JOURNAL OF HAEMATOLOGY
- Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma
- (2010) Sascha Dietrich et al. CANCER
- Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
- (2010) V. Fernandez et al. CANCER RESEARCH
- Management of Mantle Cell Lymphoma: Key Challenges and Next Steps
- (2010) Michael E. Williams et al. Clinical Lymphoma Myeloma & Leukemia
- Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting
- (2010) S. A. M. van de Schans et al. HAEMATOLOGICA
- Front-line treatment of mantle cell lymphoma
- (2010) C. H. Geisler HAEMATOLOGICA
- Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group
- (2010) R. Gressin et al. HAEMATOLOGICA
- Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
- (2010) Jia Ruan et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
- (2010) T E Witzig et al. LEUKEMIA
- Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen
- (2010) Sotirios Sachanas et al. LEUKEMIA & LYMPHOMA
- Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
- (2009) C. S. Tam et al. BLOOD
- How I treat mantle cell lymphoma
- (2009) M. Ghielmini et al. BLOOD
- The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
- (2009) C. H. Geisler et al. BLOOD
- Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
- (2009) C. Pott et al. BLOOD
- Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma
- (2009) Thomas M. Habermann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mantle cell lymphoma
- (2009) S. A. Pileri et al. HAEMATOLOGICA
- SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
- (2009) A. Mozos et al. HAEMATOLOGICA
- Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
- (2009) Niels S. Andersen et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909
- (2009) Lloyd E. Damon et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
- (2009) Peter Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
- (2009) Georg Hess et al. JOURNAL OF CLINICAL ONCOLOGY
- Current treatment standards and emerging strategies in mantle cell lymphoma
- (2009) M. Dreyling et al. Hematology-American Society of Hematology Education Program
- Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies
- (2008) P. Martin et al. ANNALS OF ONCOLOGY
- Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
- (2008) A. Goy et al. ANNALS OF ONCOLOGY
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
- (2008) C. H. Geisler et al. BLOOD
- High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen
- (2008) M Magni et al. BONE MARROW TRANSPLANTATION
- The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
- (2008) Xiao Wang et al. BRITISH JOURNAL OF HAEMATOLOGY
- High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients
- (2008) Mars B. van ’t Veer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma
- (2008) Michael Wang et al. CANCER
- Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004
- (2008) Yuhong Zhou et al. CANCER
- Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma
- (2008) Stephen M. Ansell et al. CANCER
- Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents
- (2008) L. M. Leoni et al. CLINICAL CANCER RESEARCH
- A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders
- (2008) C.E. Pedreira et al. CYTOMETRY PART A
- Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR
- (2008) Maija Itälä et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior
- (2008) S. Bea et al. HAEMATOLOGICA
- Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations
- (2008) S. Bottcher et al. HAEMATOLOGICA
- Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma
- (2008) Helena Brizova et al. INTERNATIONAL JOURNAL OF CANCER
- Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma
- (2008) Lawrence E. Garbo et al. INVESTIGATIONAL NEW DRUGS
- Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- (2008) Peter H. Wiernik et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma
- (2008) K. Sue Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
- (2008) Annina Herrmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-κ and heavy-chain gene rearrangements
- (2008) R Sutton et al. LEUKEMIA
- Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group
- (2008) Thomas E. Witzig et al. LEUKEMIA & LYMPHOMA
- The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
- (2008) Ling Lu et al. MICROVASCULAR RESEARCH
- Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma
- (2007) Peter Dreger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma
- (2007) S. Ek et al. BLOOD
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
- (2007) E. Hoster et al. BLOOD
- Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma
- (2007) Amrita Krishnan et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More